Selinexor in Combination with Decitabine Attenuates Ovarian Cancer in Mice

SIMPLE SUMMARY: Ovarian cancer is frequently discovered in the later stages. Current treatment for advanced disease ovarian cancer is inadequate and survival is poor. Our goal was to investigate how treatment with targeted therapy decitabine and/or selinexor could improve ovarian cancer in mice, whe...

Descripción completa

Detalles Bibliográficos
Autores principales: Stiff, Patrick J., Mehrotra, Swati, Potkul, Ronald K., Banerjee, Swarnali, Walker, Christopher, Drakes, Maureen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526280/
https://www.ncbi.nlm.nih.gov/pubmed/37760508
http://dx.doi.org/10.3390/cancers15184541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526280/
https://www.ncbi.nlm.nih.gov/pubmed/37760508
http://dx.doi.org/10.3390/cancers15184541

Ejemplares similares